Meridia, Sibutramine News

Family physicians should be aware that the FDA and various pharmaceutical manufacturers recently issued notifications about a number of products, including the anticonvulsant valproate sodium and related drugs; the weight-loss drug sibutramine; the osteoarthritis product diclofenac topical gel; and the protease inhibitor fosamprenavir calcium.

DOHA: The Supreme Council of Health has warned the public against using a herbal medicine - Quick Acting Slimming Capsule - manufactured by a Lebanon-based company, specialising in herbal products.

New Zealand medicines regulator Medsafe says it is aware of international concerns about weight-loss drug Reductil and is reviewing the risks.

Public Citizen , a national, nonprofit consumer advocacy organization, called for a ban on the popular weight loss drug, Meridia , today.

A consumer advocacy group is petitioning the government to ban the weight loss pill Meridia because a recent study suggests it increases risk of heart attack, stroke and death.

Preliminary data from a placebo-controlled, 10,000-patient study suggest that the antiobesity drug sibutramine may increase patients' risk of cardiovascular adverse events, FDA announced on Friday.

The FDA has issued an early communication regarding a possible increased risk for adverse cardiovascular events associated with sibutramine , a prescription drug used to manage obesity.

Nov. 23, 2009 -- A new study of the weight loss drug Meridia is in the hands of FDA regulators, who've released an early communication based on preliminary data: certain patients taking the drug may have a higher risk of heart attacks , strokes, and other serious cardiovascular problems.

The U.S. Food and Drug Administration is conducting a review of the weight loss medication sibutramine, marketed in prescription form as Meridia, due to a recent study suggesting heart problems may be associated with the medication.

FDA is reviewing preliminary data from a recent study suggesting that patients using sibutramine have a higher number of cardiovascular events than patients using a placebo.

"The analysis of these data is ongoing and FDA is making no conclusions about the preliminary findings at this time," the agency said in a statement.

Early Communication about an Ongoing Safety Review ofA A Meridia This information reflects FDA's current analysis of available data concerning this drug.

GMP Herbal Products Inc. is recalling Pai You Guo, a weight loss dietary supplement, because it contains drug ingredients not declared on the label.

A California company has recalled a weight loss supplement because it contains two undeclared ingredients that pose a health risk.

GMP Herbal Products and FDA notified consumers and healthcare professionals of a recall of Pai You Guo, a weight loss dietary supplement, due to the presence of undeclared drug ingredients.

FOR IMMEDIATE RELEASE a ' November 12, 2009 a ' Westminster, CA a ' GMP Herbal Products, Inc.

DEAR DR. GOTT: I read your column every day and am writing to you because of your willingness to share information on remedies that have been reported successful by your readers.

Dear Dr. Gott: The recent article on the difficulty in treating fibromyalgia reinforces the urgency in making available sibutramine hydrochloride monohydrate to FM sufferers.

Brain Serotonin Transporter Occupancy by Oral Sibutramine Dosed to Steady State: A PET Study Using 11C-DASB in Healthy Humans 1Wolfson Molecular Imaging Centre, The University of Manchester, Manchester, UK 2Icon Development Solutions, Manchester, UK 3Manchester Academic Health Science Centre, Stopford Building, The University of Manchester, ...

Recent technological developments in the sequence capture of cellular events through a light microscope can be combined to image multiple independent experiments automatically, with many advantages.